BICO Group AB (BICO) - Net Assets
Based on the latest financial reports, BICO Group AB (BICO) has net assets worth Skr1.81 Billion SEK (≈ $194.97 Million USD) as of August 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr3.74 Billion ≈ $402.85 Million USD) and total liabilities (Skr1.93 Billion ≈ $207.88 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check BICO Group AB (BICO) asset resilience to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Skr1.81 Billion |
| % of Total Assets | 48.4% |
| Annual Growth Rate | 145.02% |
| 5-Year Change | 97.53% |
| 10-Year Change | N/A |
| Growth Volatility | 793.67 |
BICO Group AB - Net Assets Trend (2016–2024)
This chart illustrates how BICO Group AB's net assets have evolved over time, based on quarterly financial data. Also explore total assets of BICO Group AB for the complete picture of this company's asset base.
Annual Net Assets for BICO Group AB (2016–2024)
The table below shows the annual net assets of BICO Group AB from 2016 to 2024. For live valuation and market cap data, see BICO stock market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2024-08-31 | Skr3.01 Billion ≈ $323.67 Million |
-2.99% |
| 2023-08-31 | Skr3.10 Billion ≈ $333.64 Million |
-55.28% |
| 2022-08-31 | Skr6.93 Billion ≈ $746.02 Million |
+1.90% |
| 2021-08-31 | Skr6.80 Billion ≈ $732.08 Million |
+346.78% |
| 2020-08-31 | Skr1.52 Billion ≈ $163.86 Million |
+177.02% |
| 2019-08-31 | Skr549.64 Million ≈ $59.15 Million |
+195.25% |
| 2018-08-31 | Skr186.16 Million ≈ $20.03 Million |
+210.02% |
| 2017-08-31 | Skr60.05 Million ≈ $6.46 Million |
+2493.82% |
| 2016-08-31 | Skr2.31 Million ≈ $249.13K |
-- |
Equity Component Analysis
This analysis shows how different components contribute to BICO Group AB's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 486094800000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (August 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | Skr1.80 Million | 0.06% |
| Other Components | Skr7.84 Billion | 262.81% |
| Total Equity | Skr2.98 Billion | 100.00% |
BICO Group AB Competitors by Market Cap
The table below lists competitors of BICO Group AB ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Clavister Holding AB (publ.)
ST:CLAV
|
$159.89 Million |
|
Kao Fong Machinery Co Ltd
TWO:4510
|
$160.06 Million |
|
Bank Capital Indonesia Tbk
JK:BACA
|
$160.18 Million |
|
Asia Pacific Satellite Inc
KQ:211270
|
$160.21 Million |
|
Mayne Pharma Group Ltd
AU:MYX
|
$159.81 Million |
|
Ilyang Pharmaceutical Co Ltd
KO:007575
|
$159.79 Million |
|
UmweltBank AG
XETRA:UBK
|
$159.79 Million |
|
Muhak Co. Ltd
KO:033920
|
$159.75 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in BICO Group AB's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 3,074,900,000 to 2,985,000,000, a change of -89,900,000 (-2.9%).
- Net loss of 5,500,000 reduced equity.
- New share issuances of 3,600,000 increased equity.
- Other factors decreased equity by 88,000,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Skr-5.50 Million | -0.18% |
| Share Issuances | Skr3.60 Million | +0.12% |
| Other Changes | Skr-88.00 Million | -2.95% |
| Total Change | Skr- | -2.92% |
Book Value vs Market Value Analysis
This analysis compares BICO Group AB's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.51x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 232.10x to 0.51x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-08-31 | Skr0.09 | Skr21.50 | x |
| 2017-08-31 | Skr2.23 | Skr21.50 | x |
| 2018-08-31 | Skr6.03 | Skr21.50 | x |
| 2019-08-31 | Skr15.65 | Skr21.50 | x |
| 2020-08-31 | Skr35.92 | Skr21.50 | x |
| 2021-08-31 | Skr110.41 | Skr21.50 | x |
| 2022-08-31 | Skr103.25 | Skr21.50 | x |
| 2023-08-31 | Skr43.57 | Skr21.50 | x |
| 2024-08-31 | Skr42.30 | Skr21.50 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently BICO Group AB utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -0.18%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -0.28%
- • Asset Turnover: 0.35x
- • Equity Multiplier: 1.84x
- Recent ROE (-0.18%) is above the historical average (-7.11%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2017 | 0.26% | 1.18% | 0.19x | 1.15x | Skr-5.85 Million |
| 2018 | 0.64% | 2.61% | 0.23x | 1.05x | Skr-17.43 Million |
| 2019 | 0.11% | 0.55% | 0.17x | 1.10x | Skr-54.38 Million |
| 2020 | -4.08% | -35.01% | 0.11x | 1.09x | Skr-213.63 Million |
| 2021 | -3.38% | -18.23% | 0.13x | 1.44x | Skr-906.59 Million |
| 2022 | -12.10% | -37.32% | 0.22x | 1.48x | Skr-1.53 Billion |
| 2023 | -38.14% | -58.33% | 0.33x | 1.97x | Skr-1.48 Billion |
| 2024 | -0.18% | -0.28% | 0.35x | 1.84x | Skr-304.00 Million |
Industry Comparison
This section compares BICO Group AB's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $190,373,253
- Average return on equity (ROE) among peers: -31.02%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| BICO Group AB (BICO) | Skr1.81 Billion | 0.26% | 1.07x | $159.82 Million |
| Acarix A/S (ACARIX) | $15.12 Million | -127.02% | 0.21x | $33.84 Million |
| Arcoma AB (ARCOMA) | $48.66 Million | 5.27% | 0.68x | $11.55 Million |
| Bactiguard Holding AB (publ) (BACTI-B) | $387.11 Million | -0.84% | 0.62x | $61.64 Million |
| Boule Diagnostics AB (BOUL) | $295.74 Million | 7.87% | 0.93x | $14.38 Million |
| CellaVision AB (CEVI) | $887.58 Million | 17.25% | 0.23x | $311.10 Million |
| Clinical Laserthermia Systems AB (publ) (CLS-B) | $26.09 Million | -70.24% | 0.12x | $11.57 Million |
| Chordate Medical Holding AB (CMH) | $25.64 Million | -77.06% | 0.22x | $29.05K |
| C-Rad AB (publ) (CRAD-B) | $29.82 Million | -34.38% | 0.50x | $86.08 Million |
| Duearity AB (DEAR) | $-2.39 Million | 0.00% | 0.00x | $331.97K |
About BICO Group AB
BICO Group AB (publ) provides hardware, laboratory automation, and software solutions in North America, Europe, Asia, and internationally. It operates through three segments: Bioprinting, Life Science Solutions, and Lab Automation. The Bioprinting segment offers 3D bioprinters and bioinks with a range of technologies for various applications, resolutions, and volume/speed requirements, as well as… Read more